chrM-4277-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The ENST00000387365.1(MT-TI):n.15T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Mitomap GenBank:
𝑓 0.00030 ( AC: 20 )
Consequence
MT-TI
ENST00000387365.1 non_coding_transcript_exon
ENST00000387365.1 non_coding_transcript_exon
Scores
Mitotip
Benign
Clinical Significance
HCM-/-Poss.-hypertension-factor
Conservation
PhyloP100: -1.85
Genes affected
MT-TI (HGNC:7488): (mitochondrially encoded tRNA isoleucine)
MT-ND1 (HGNC:7455): (mitochondrially encoded NADH dehydrogenase 1) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial membrane. Part of mitochondrial respiratory chain complex I. Implicated in several diseases, including MELAS syndrome; neurodegenerative disease (multiple); optic nerve disease (multiple); toxic shock syndrome; and type 2 diabetes mellitus. Biomarker of Alzheimer's disease; Parkinson's disease; and multiple sclerosis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant M-4277-T-C is Benign according to our data. Variant chrM-4277-T-C is described in ClinVar as [Benign]. Clinvar id is 235012.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomadMitoHomoplasmic at 9
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNI | TRNI.1 use as main transcript | n.15T>C | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-TI | ENST00000387365.1 | n.15T>C | non_coding_transcript_exon_variant | 1/1 | ||||||
MT-ND1 | ENST00000361390.2 | downstream_gene_variant | ENSP00000354687 | P1 |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
20
Gnomad homoplasmic
AF:
AC:
9
AN:
56430
Gnomad heteroplasmic
AF:
AC:
1
AN:
56430
Alfa
AF:
Hom.:
Mitomap
HCM-/-Poss.-hypertension-factor
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Nov 09, 2011 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MT-TI m.4277 T>C Given the lack of conservation in that region and lack of reported case data, (reviewed below) we consider this variant a variant of uncertain significance. This variant has been reported previously in one study examining the relationship between mitochondrial tRNA genes and hypertension, however a functional link between this variant and hypertension was not assessed in this study (Maron B et al., 2002). The 4277 position in the MT-TI gene is not highly conserved across species, with several species harboring a cytosine "C" nucleotide at this position. This variant is located in the DHU-loop of MT-TI and it is not predicted to alter the secondary structure of the tRNA-Gly. The variant has not been observed in various control populations of 2704 to 6391 individuals (Mitomap, mtDB, MItoWheel). - |
Juvenile myopathy, encephalopathy, lactic acidosis AND stroke Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Jul 12, 2019 | The NC_012920.1:m.4277T>C variant in MT-TI gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS4, BP4 - |
not provided Other:1
not provided, no classification provided | phenotyping only | GenomeConnect-Association for Creatine Deficiencies, Association for Creatine Deficiencies | - | Variant interpreted as Uncertain significance and reported on 06-08-2017 by GTR ID 1006. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect facilitates ClinVar submission from the Association for Creatine Deficiencies registry and does not attempt to reinterpret the variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Benign
Hmtvar
Pathogenic
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at